Requirements instituted to address racial and ethnic disparities in clinical trial enrollment did not lead to increased inclusion of Black and Hispanic participants in clinical acute leukemia research, according to […]
The U.S. Food and Drug Administration (FDA) has issued its latest guidance in a series designed to provide general considerations to assist sponsors in assuring the safety of trial participants, […]
The European Medicines Agency (EMA) and the European Union’s Heads of Medicines Agencies have signed off on a new plan and taskforce with big ambitions to improve the integration of […]
From bench to bedside, the journey toward new cancer therapies is full of challenges. Clinical trials—where new treatments are tested on people—are vital, but with fewer than 5% of cancer […]
Black adults are disproportionately affected by cardiovascular disease but underrepresented in relevant clinical research trials in the United States. In a new paper published in the Journal of the American […]